Lidocaine Hydrochloride Injection — FDA Drug Shortage

Current — Hospira, Inc., A Pfizer Company

The FDA lists a drug shortage record for Lidocaine Hydrochloride Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Feb 22, 2012.

Shortage details

Status
Current
Company
Hospira, Inc., A Pfizer Company
Package NDC
0409-4278-01
Dosage Form
Injection
Presentation
Lidocaine Hydrochloride, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4278-01)
Initial Posting
Feb 22, 2012

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.